New Delhi: Leading digital healthcare platform Practo on Saturday mentioned it has partnered with diagnostic lab chain Thyrocare to conduct Covid-19 detection assessments authorised by the federal government and the Indian Council of Medical Research (ICMR).
Starting Saturday, the test is available for Mumbai residents for Rs 4,500, and can quickly be expanded to the remainder of the nation, Practo mentioned.
A sound physician’s prescription, duly crammed Test Requisition Form signed by the doctor, and a photograph ID card must be offered on the time of testing.
“To ensure that anyone who experiences the symptoms of the infection can get tested, the government is constantly working on expanding the list of labs and centers,” Alexander Kuruvilla, Chief Health Strategy Officer, Practo, mentioned in a press release.
“We’ve partnered with Thyrocare to ensure that access to these tests is not an issue. We will continue to work closely with the authorities to identify more such areas where Practo can solve for accessibility – be it for doctor consultations, testing or medicine delivery,” Kuruvilla added.
Certified phlebotomists from house healthcare service supplier I2H will gather the samples from the sufferers’ houses straight, Practo mentioned, including that the swab that’s taken through the test can be collected in a viral transport medium (VTM) and can be transported in a chilly chain to the Thyrocare laboratory which has been chosen for COVID-19 testing.
The report can be made available to the sufferers on the Practo web site inside 24-48 hours of the pattern assortment, the corporate added.